Literature DB >> 22502717

Quality of life and radiotherapy complications of Chinese nasopharyngeal carcinoma patients at different 3DCRT.

Mo-Fa Gu1, Yong Su, Xin-Lin Chen, Wei-Ling He, Zhen-Yu He, Jian-Jun Li, Miao-Qiu Chen, Chuan-Wei Mo, Qian Xu, Yuan-Ming Diao.   

Abstract

PURPOSE: the study aimed to compare the quality of life (QOL) and radiotherapy complications among Chinese nasopharyngeal carcinoma (NPC) patients at different 3-dimensional conformal radiotherapy (3DCRT) stages adjusting for other variables.
METHODS: 511 NPC patients at different 3DCRT stages were enrolled. They were interviewed regarding SF-36, complications and socio-demographic variables and cancer- or treatment- related variables. Analysis of covariance (ANCOVA) based on SF-36, complications scores as dependent variables, 3DCRT stages as independent variables, and other variables as covariate were established.
RESULTS: The influencing factors of PCS included 3DCRT stages and age group. The influencing factors of MCS included 3DCRT stages and income. Most QOL scores of NPC patients were significantly associated with 3DCRT stage, after accounting for other variables. QOL scores of the patients receiving 3DCRT were the lowest, QOL scores of people after 3DCRT gradually increased. PCS scores of people greater than 5 years after 3DCRT was improved to or even better than the level before 3DCRT. The complications with significantly different scores of patients at different 3DCRT status included xerostomia, throat ache, hypogeusia, caries, hearing loss, snuffles.
CONCLUSIONS: Clinicians should pay more attention to older NPC patients and patients with lower income. When patients receive 3DCRT, measures should be taken to reduce radiation injury to improve the patients' QOL.

Entities:  

Mesh:

Year:  2012        PMID: 22502717     DOI: 10.7314/apjcp.2012.13.1.075

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy.

Authors:  Minying Li; Jingjing Zhang; Yawen Zha; Yani Li; Bingshuang Hu; Siming Zheng; Jiaxiong Zhou
Journal:  BMC Oral Health       Date:  2022-06-17       Impact factor: 3.747

2.  Development and validation of quality of life scale of nasopharyngeal carcinoma patients: the QOL-NPC (version 2).

Authors:  Yong Su; Chuan-Wei Mo; Wan-Qin Cheng; Lei Wang; Qian Xu; Zu-Chun Wu; Zhe-Li Wu; Li-Zhi Liu; Xin-Lin Chen
Journal:  Health Qual Life Outcomes       Date:  2016-05-10       Impact factor: 3.186

3.  Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy.

Authors:  Xin-Bin Pan; Shi-Ting Huang; Kai-Hua Chen; Yan-Ming Jiang; Jia-Lin Ma; Song Qu; Ling Li; Long Chen; Xiao-Dong Zhu
Journal:  Oncotarget       Date:  2017-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.